MedTrace Logo

GLOBAL Clinical Study

NCT01738828 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2016-02-09

No results posted yet for this study

Summary

The GLOBAL study is an international multi-center, prospective study designed to enroll up to 10,000 consecutive eligible subjects who are clinically referred for coronary CT angiography for assessment of suspected coronary artery disease (CAD).

The purpose of the study is to perform extensive biomarker analysis of atherosclerosis in patients phenotyped using advanced imaging modalities of atherosclerosis.

Conditions

Sponsors & Collaborators

  • Global Genomics Group, LLC

    lead INDUSTRY

Principal Investigators

  • Szilard Voros, MD · Global Genomics Group, LLC

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-05-31
Completion
2016-12-31

Countries

  • United States
  • Australia
  • Canada
  • Croatia
  • Germany
  • Hungary
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01738828 on ClinicalTrials.gov